Atlas Trials

Akt Inhibitor MK2206 in Treating Patients With Advanced Breast Cancer

Clinical trial NCT01277757 · COMPLETED

Trial details

NCT number
NCT01277757
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent Breast CarcinomaStage IIIB Breast CancerStage IIIC Breast CancerStage IV Breast Cancer
Start date
2011-03-01
Primary completion
2014-08-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.